Consistency of the bootstrap procedure in individual bioequivalence

Biometrika

Volumn 87, Issue 3, 2000, Pages 573-585

  Shao, Jun ^a   Kübler, Jürgen ^b   Pigeot, Iris ^c  

^a University of Wisconsin Madison   (United States)

^b BAYER AG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bioequivalence; Bootstrap percentile; Consistency

Indexed keywords

EID: 0000010050     PISSN: 00063444     EISSN: None     Source Type: Journal    
DOI: 10.1093/biomet/87.3.573     Document Type: Article

References (27)

1. ANDERSON, S. & HAUCK, W. W. (1990). Consideration of individual bioequivalence. J. Pharmacokin. Biopharm. 18, 259-73.
2. CHEN, M.-L. (1997). Individual bioequivalence - a regulatory update. J. Biopharm. Statist. 7, 5-11.
3. CHINCHILLI, V. M. (1996). The assessment of individual and population bioequivalence. J. Biopharm. Statist. 6, 1-14.
4. CHOW, S. C. & LIU, J. P. (1995). Current issues in bioequivalence trials. Drug Inf. J. 29, 795-804.
5. EFRON, B. & TIBSHIRANI, R. J. (1993). An Introduction to the Bootstrap. New York: Chapman & Hall.
6. EKBOHM, G. & MELANDER, H. (1989). The subject-by-formulation interaction as a criterion of interchangeability of drugs. Biometrics 45, 1249-54.
7. ENDRENYI, L. (1994). A method for the evaluation of individual bioequivalence. Int. J. Clin. Pharmacol. Ther. 32, 497-508.
8. ESINHART, J. D. & CHINCHILLI, V. M. (1994). Extension to the use of tolerance intervals for the assessment of individual bioequivalence. J. Biopharm. Statist. 4, 39-52.
9. FOOD AND DRUG ADMINISTRATION (1997). In Vivo Bioequivalence Studies Based on Population and Individual Bioequivalence Approaches, Draft Guidance for Industry. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration.
10. HAUCK, W. W. & ANDERSON, S. (1992). Types of bioequivalence and related statistical considerations. Int. J. Clin. Pharmacol. Ther. Toxicol. 30, 181-7.
11. HAUCK, W. W. & ANDERSON, S. (1994). Measuring switchability and prescribability: when is average bioequivalence sufficient? J. Pharmacokin. Biopharm. 22, 551-64.
12. HAUSCHKE, D., KIESER, M., DILETTI, E. & BURKE, M. (1999). Sample size determination for proving equivalence based on the ratio of two means for normally distributed data. Statist. Med. 18, 93-105.
13. HAUSCHKE, D. & STEINIJANS, V. W. (2000). The U.S. draft guidance regarding population and individual bioequivalence approaches: comments by research-based pharmaceutical company. Statist. Med. 19. To appear.
14. HOLDER, D. J. & HSUAN, F. (1993). Moment-based criteria for determining bioequivalence. Biometrika 80, 835-46.
15. HWANG, J. T. G. & WANG, W. (1997). The validity of the test of individual equivalence ratios. Biometrika 84, 893-900.
16. KIMANANI, E. K. & POTVIN, D. (1997). A parametric confidence interval for a moment-based scaled criterion for individual bioequivalence. J. Pharmacokin. Biopharm. 25, 595-614.
17. PATNAIK, R. N., LESKO, L. J., CHEN, M. L. & WILLIAMS, R. L. (1997). Individual bioequivalence. New concepts in the statistical assessment of bioequivalence metrics. Clin. Pharmacokinet. 33, 1-6.
18. SCHALL, R. (1995). Assessment of individual and population bioequivalence using the probability that bioavail-abilities are similar. Biometrics 51, 615-26.
19. SCHALL, R. & LUUS, H. G. (1993). On population and individual bioequivalence. Statist. Med. 12, 1109-24.
20. SCHALL, R. & WILLIAMS, R. L. (1996). Towards a practical strategy for assessing individual bioequivalence. J. Pharmacokin. Biopharm. 24, 133-49.
21. SERFLING, R. J. (1980). Approximation Theorems of Mathematical Statistics. New York: Wiley.
22. SHAO, J. (1994). Bootstrap sample size in nonregular cases. Proc. Am. Math. Soc. 122, 1251-62.
23. SHAO, J. & CHEN, Y. (1998). Bootstrapping sample quantiles based on complex survey data under hot deck imputation. Statist. Sinica 8, 1071-85.
24. SHAO, J., CHOW, S.-C. & WANG, B. (2000). The bootstrap procedure in individual bioequivalence. Statist. Med. 19. To appear.
25. SHAO, J. & TU, D. (1995). The Jackknife and Bootstrap. New York: Springer.
26. SHEINER, L. B. (1992). Bioequivalence revisited. Statist. Med. 11, 1777-88.
27. SHUMAKER, R. C. & METZLER, C. M. (1998). The Phenytoin trial is a case study of 'individual' bioequivalence. Drug. Inf. J. 32, 1063-72.